{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Atypical haemolytic uraemic syndrome",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_eculizumab",
          "name": "Eculizumab"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_ravulizumab",
          "name": "Ravulizumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_aflibercept",
          "name": "Aflibercept"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_plasmapheresis",
          "name": "Plasmapheresis"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_tacrolimus",
          "name": "Tacrolimus"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_copanlisib",
          "name": "Copanlisib"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_belimumab",
          "name": "Belimumab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_sunitinib",
          "name": "Sunitinib"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_aflibercept",
          "type": "Drug",
          "label": "Aflibercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_plasmapheresis",
          "type": "Drug",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tacrolimus",
          "type": "Drug",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_copanlisib",
          "type": "Drug",
          "label": "Copanlisib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_belimumab",
          "type": "Drug",
          "label": "Belimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sunitinib",
          "type": "Drug",
          "label": "Sunitinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "DiseaseAtypicalHUS",
          "type": "Disease",
          "label": "Atypical HUS",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_CD5",
          "type": "Target",
          "label": "CD5",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_inflammatory_response",
          "type": "Pathway",
          "label": "Inflammatory Response",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "phenotype_renal_failure",
          "type": "Phenotype",
          "label": "Renal Failure",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "phenotype_thrombocytopenia",
          "type": "Phenotype",
          "label": "Thrombocytopenia",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_eculizumab",
          "target": "target_CD5",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知的机制作用"
        },
        {
          "source": "drug_ravulizumab",
          "target": "target_CD5",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知的机制作用"
        },
        {
          "source": "drug_aflibercept",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通路间接调节"
        },
        {
          "source": "drug_corticosteroids",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "通路中常用药物"
        },
        {
          "source": "drug_plasmapheresis",
          "target": "phenotype_renal_failure",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "临床通过形式改善症状"
        },
        {
          "source": "drug_methotrexate",
          "target": "phenotype_thrombocytopenia",
          "relation": "involved_in",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "具有影响血小板的潜力"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "phenotype_thrombocytopenia",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "具有影响血小板的潜力"
        },
        {
          "source": "drug_tacrolimus",
          "target": "phenotype_renal_failure",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "在肾脏相关代谢方面的应用"
        },
        {
          "source": "target_CD5",
          "target": "pathway_inflammatory_response",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "关键靶点关联"
        },
        {
          "source": "pathway_inflammatory_response",
          "target": "DiseaseAtypicalHUS",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "与此型疾病的发病机制相关"
        },
        {
          "source": "drug_eculizumab",
          "target": "DiseaseAtypicalHUS",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "直接针对已知病理机制"
        },
        {
          "source": "drug_ravulizumab",
          "target": "DiseaseAtypicalHUS",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "直接针对已知病理机制"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "Eculizumab与Ravulizumab等药物可以通过通过影响CD5靶点与炎症通路来对抗Atypical HUS。",
        "confidence": "high"
      },
      {
        "id": "C2",
        "text": "其他药物如Corticosteroids和Plasmapheresis可能通过相关表型改善症状。",
        "confidence": "medium"
      }
    ],
    "assumptions": [
      "所有药物具备到达目标组织与通路的最小暴露水平"
    ],
    "uncertainties": [
      "部分药物在特定病理情况的有效性仍需进一步研究"
    ],
    "next_focus_for_pi": [
      "考虑是否将更多靶点及路径进行扩展"
    ]
  }
}